সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

sintetica sa - pethidini hydrochloridum - pethidin hci sintetica 50 mg/ml soluzione iniettabile - pethidini hydrochloridum 50 mg, natrii hydroxidum corresp. natrium max. 0.002 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - analgesico stupefacente - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

vertex pharmaceuticals (ch) gmbh - elexacaftorum, tezacaftorum, ivacaftorum - 75 mg, filmtabletten - filmtablette morgendosis (elexacaftorum 50 mg / tezacaftorum 25 mg / ivacaftorum 37.5 mg): elexacaftorum 50 mg, tezacaftorum 25 mg, ivacaftorum 37.5 mg, hypromellosum, hypromellosi acetas succinas, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, e 171, talcum, e 172 (flavum), e 172 (rubrum) pro compresso obducto corresp. natrium 1.34 mg. filmtablette abenddosis (ivacaftorum 75 mg): ivacaftorum 75 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, lactosum monohydricum 83.6 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 132, cera carnauba, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum pro compresso obducto corresp. natrium 0.9 mg. - la fibrosi cistica - synthetika

ইউরোপীয় ইউনিয়ন - ইতালীয় - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

ইউরোপীয় ইউনিয়ন - ইতালীয় - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

ইউরোপীয় ইউনিয়ন - ইতালীয় - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - farmaci usati nel diabete - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - pregabalinum - capsule - pregabalinum 50 mg, mannitolum, amylum pregelificatum, talcum, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum pro capsula. - antiepilepticum, dolore neuropatico, disturbo d'ansia generalizzata - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - pregabalinum - capsule rigide - pregabalinum 50 mg, lactosum monohydricum 130 mg, maydis amylum, talcum, kapselhülle: gelatina, e 171, e 172 (rubrum) pro capsula. - neuropathische schmerzen, epilepsie, generalisierte angststörungen - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - pregabalinum - capsule rigide - pregabalinum 150 mg, lactosum monohydricum 16.50 mg, maydis amylum, talcum, kapselhülle: gelatina, e 171 pro capsula. - neuropathische schmerzen, epilepsie, generalisierte angststörungen - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

ucb-pharma sa - lacosamidum - compresse rivestite con film - lacosamidum 50 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, cellulosum microcristallinum silicificatum, crospovidonum, magnesii stearas, hydroxypropylcellulosum, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, e 132, e 171, e 172 (rubrum), e 172 (nigrum) pro compresso obducto. - aed - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

ucb-pharma sa - lacosamidum - compresse rivestite con film - lacosamidum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, cellulosum microcristallinum silicificatum, crospovidonum, magnesii stearas, hydroxypropylcellulosum, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum) pro compresso obducto. - aed - synthetika